+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
CAPLIPOINT

Caplin Point Laboratories Share Price

 
Near 52W High of ₹2699.00

 

Caplin Point Laboratories live price: ₹2,588.30. It opened at ₹2,639 vs previous close ₹2,621; intraday high/low: ₹2,675/₹2,575. The 50 & 200 DMA stand at ₹2,382.10/₹2,063.50.

Caplin Point Laboratories Performance

  • Today's Low
  • ₹2,575
  • Today's High
  • ₹2,675
  • 52 Week Low
  • ₹1,500
  • 52 Week High
  • ₹2,699
  • Open Price₹2,639
  • Previous Close₹2,621
  • Volume115,659
  • 50 DMA₹2,382.10
  • 100 DMA₹2,191.40
  • 200 DMA₹2,063.50

Caplin Point Laboratories Chart

Investment Returns

  • Over 1 Month + 3.27%
  • Over 3 Month + 46.97%
  • Over 6 Month + 49.56%
  • Over 1 Year + 27.07%

Smart Investing Starts Here Start SIP with Caplin Point Laboratories for Steady Growth!

Invest Now

Caplin Point Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 30.7
  • PEG Ratio
  • 1.6
  • Market Cap Cr
  • 19,674
  • P/B Ratio
  • 5.5
  • Average True Range
  • 100.6
  • EPS
  • 84.4
  • Dividend Yield
  • 0.3
  • MACD Signal
  • 48.7
  • RSI
  • 55.58
  • MFI
  • 60.49

Latest Stock News Updates

Caplin Point Laboratories Ltd - 524742 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Intimation pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018 for the quarter ended June 30, 2026

Caplin Point Laboratories Ltd - 524742 - Closure of Trading Window

Intimation of closure of Trading Window commencing from July 01, 2026

Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper advertisement for transfer of Unclaimed dividend and shares to IEPF

Caplin Point Laboratories Financials

Caplin Point Laboratories Technicals

EMA & SMA

Current Price
₹2,588.30
-33.1 (-1.26%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹2,549.60
  • 50 Day
  • ₹2,382.10
  • 100 Day
  • ₹2,191.40
  • 200 Day
  • ₹2,063.50

Resistance and Support

2612.77 Pivot Speed
  • R3 2,750.50
  • R2 2,712.80
  • R1 2,650.50
  • S1 2,550.50
  • S2 2,512.80
  • S3 2,450.50

Caplin Point Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-14 Audited Results & Interim Dividend
2026-02-05 Quarterly Results
2025-11-05 Quarterly Results
2025-08-07 Quarterly Results, Final Dividend & A.G.M.
2025-05-15 Audited Results & Interim Dividend
Date Purpose Remarks
2026-05-30 INTERIM Rs.4.00 per share(200%)Interim Dividend
2025-09-12 FINAL Rs.3.00 per share(150%)Final Dividend
2025-05-30 INTERIM Rs.3.00 per share(150%)Interim Dividend
2024-05-31 INTERIM Rs.2.50 per share(125%)Interim Dividend
2023-06-09 INTERIM Rs.2.00 per share(100%)Interim Dividend
View Caplin Point Laboratories Dividend History Arrow
Date Purpose Remarks
2016-10-20 Split

Caplin Point Laboratories Shareholding Pattern

70.57%
21.19%
5.76%
2.03%
0.46%

About Caplin Point Laboratories

Caplin Point Laboratories manufactures wide range of ointments, creams and other external application preparations in addition to the regular segments of pharmaceutical formulations. View More
  • NSE Symbol
  • CAPLIPOINT
  • BSE Symbol
  • 524742
  • ISIN
  • INE475E01026

Similar Stocks to Caplin Point Laboratories

Caplin Point Laboratories FAQs

Caplin Point Laboratories share price is ₹2,588 As on 29 July, 2026 | 04:30

The Market Cap of Caplin Point Laboratories is ₹19674.1 Cr As on 29 July, 2026 | 04:30

The P/E ratio of Caplin Point Laboratories is 30.7 As on 29 July, 2026 | 04:30

The PB ratio of Caplin Point Laboratories is 5.5 As on 29 July, 2026 | 04:30

The 52 week High & Low of Caplin Point Laboratories is ₹2699/₹1500.3 respectively As on 29 July, 2026 | 04:30

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23